Cyrano Therapeutics has acquired an exclusive license to use Resyca’s soft mist nasal spray technology for delivery of CYR-064 intranasal theophylline for the treatment of post-viral hyposmia. According to the announcement, the Phase 2 FLAVOR study of CYR-064 that was initiated in 2023 has been using an Ursatec spray pump enhanced with the Resyca technology for … [Read more...] about Cyrano licenses Resyca’s soft mist technology for delivery of CYR-064 intranasal theophylline for the treatment of post-viral loss of smell
Products and Services
Renaissance Lakewood to provide development services for Tiziana’s intranasal foralumab
Tiziana Life Sciences announced that it has contracted with CDMO Renaissance Lakewood for development services related to Tiziana's intranasal foralumab anti-CD3 monoclonal antibody. According to Tiziana, the project includes optimization of the formulation and development of "a comprehensive plan for the scale-up of foralumab in a nasal device." Tiziana is … [Read more...] about Renaissance Lakewood to provide development services for Tiziana’s intranasal foralumab
Zeteo Biomedical launches CygnusMR and Cygnus SDX dry powder nasal delivery devices
Texas-based Zeteo Biomedical has announced the launch of two new devices for intranasal delivery of dry powders: the CygnusMR multi-dose device and the CygnusSDX single dose disposable device. In 2022, the company announced the launch of its ZEOx1 OrionMRQ multi-dose nasal device for delivery of liquid drugs and vaccines. According to Zeteo, the new dry powder nasal … [Read more...] about Zeteo Biomedical launches CygnusMR and Cygnus SDX dry powder nasal delivery devices
Inhalon announces plans for Phase 2a challenge study of IN-002 inhaled antibody against RSV
Inhalon Biopharma announced that it has contracted with hVIVO to conduct a Phase 2a challenge study of nebulized IN-002, an antibody against RSV, now that Inhalon has completed IND-enabling studies. The company said that it expects to initiate the trial of IN-002 in 2026. Inhalon's pipeline of inhaled antibodies also includes IN-003 against metapneumovirus, IN-005 … [Read more...] about Inhalon announces plans for Phase 2a challenge study of IN-002 inhaled antibody against RSV
Kenox Pharmaceuticals adds small scale GMP capability for OINDPs
OINDP specialist contract developer Kenox Pharmaceuticals announced that it has added a clean room for small scale manufacturing of non-sterile nasal sprays and dry powders for use in pre-clinical development. The company, which is located in Princeton, NJ, USA, said that it is also in the process of adding Phase 1 and 2 clinical scale GMP manufacturing capabilities … [Read more...] about Kenox Pharmaceuticals adds small scale GMP capability for OINDPs
Copley Scientific introduces new Powder Testing Workstation PTW and Powder Testing Assistant PTA 100i
OINDP testing specialists Copley Scientific have announced the launch of the new Powder Testing Workstation PTW for flowability testing as well as the Powder Testing Assistant PTA 100i. The customizable PTW system allows the user to select various modules for angle of repose, flow through an orifice, and bulk density testing of dry powders. The PTA 100i offers … [Read more...] about Copley Scientific introduces new Powder Testing Workstation PTW and Powder Testing Assistant PTA 100i
KAER Bio launches AeroPulsR high dose delivery system for critical care use
KAER Biotherapeutics has announced the launch of the AeroPulsR aerosol device for delivery of high doses of aqueous aerosols in critical care settings. According to KAER, the AeroPulsR can deliver liquids of viscosities up to 50 cP as aerosols with particle sizes in the 2-4 μm range. The device also can deliver aerosols in continuous, periodic, or spontaneous … [Read more...] about KAER Bio launches AeroPulsR high dose delivery system for critical care use
Nemera and Nipro announce compatibility of Nemera’s UniSpray nasal pump and Nipro’s unit dose vials
Nemera and Nipro Pharma Packaging have announced the conclusion of compatibility testing of Nemera’s UniSpray nasal pump with Nipro’s unit dose "microvials." According to the companies, the tests demonstrated complete compatibility and meet requirements for reliability and dose delivery. Nemera announced the launch of the UniSpray single metered dose nasal pump, … [Read more...] about Nemera and Nipro announce compatibility of Nemera’s UniSpray nasal pump and Nipro’s unit dose vials
DFE Pharma adds services for DPIs at Center of Excellence in Hyderabad
Lactose supplier DFE Pharma has announced the availability of analytical services for dry powder inhaler formulations at its Closer to the Formulator (C2F) Center of Excellence in Hyderabad, India, in response to growing demand. According to DFE, the center opened in 2022 but only offered services for oral solid dosage forms until now. Newly available services at … [Read more...] about DFE Pharma adds services for DPIs at Center of Excellence in Hyderabad
Lonza to develop spray dried formulations of a dry powder intranasal biologic for Iconovo
Spray drying experts Lonza will develop spray dried dry powder formulations for delivery by Iconovo's ICOone Nasal device, the companies announced. According to the announcement, the collaboration involves "a reformulated substance for obesity." In May 2024, Iconovo said that it intended to develop inhaled GLP-1 receptor agonists for the treatment of … [Read more...] about Lonza to develop spray dried formulations of a dry powder intranasal biologic for Iconovo